These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8862014)
1. Topology of MDR1-P-glycoprotein as indicated by epitope mapping of monoclonal antibodies to human MDR cells. Cianfriglia M; Poloni F; Signoretti C; Romagnoli G; Tombesi M; Felici F Cytotechnology; 1996; 19(3):247-51. PubMed ID: 8862014 [TBL] [Abstract][Full Text] [Related]
2. Isolation of antigenic mimics of MDR1-P-glycoprotein by phage-displayed peptide libraries. Poloni F; Romagnoli G; Cianfriglia M; Felici F Int J Cancer; 1995 May; 61(5):727-31. PubMed ID: 7768648 [TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein epitope mapping. II. The murine monoclonal antibody MM6.15 to human multidrug-resistant cells binds with three distinct loops in the MDR1-P-glycoprotein extracellular domain. Cianfriglia M; Romagnoli G; Tombesi M; Poloni F; Falasca G; Di Modugno F; Castagna M; Chersi A Int J Cancer; 1995 Mar; 61(1):142-7. PubMed ID: 7705928 [TBL] [Abstract][Full Text] [Related]
4. A new immunohistochemical methodology for the specific detection of MDR1-P-glycoprotein in human tissues based on phage-displayed peptides mimicking the MM4.17 epitope. Poloni F; Castagna M; Felici F; Cianfriglia M Biol Chem; 1997 Jun; 378(6):503-7. PubMed ID: 9224930 [TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein epitope mapping. I. Identification of a linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi-drug-resistant cells. Cianfriglia M; Willingham MC; Tombesi M; Scagliotti GV; Frasca G; Chersi A Int J Cancer; 1994 Jan; 56(1):153-60. PubMed ID: 7505264 [TBL] [Abstract][Full Text] [Related]
6. Epitope mapping of the monoclonal antibody MM12.10 to external MDR1 P-glycoprotein domain by synthetic peptide scanning and phage display technologies. Romagnoli G; Poloni F; Flego M; Moretti F; Di Modugno F; Chersi A; Falasca G; Signoretti C; Castagna M; Cianfriglia M Biol Chem; 1999 May; 380(5):553-9. PubMed ID: 10384961 [TBL] [Abstract][Full Text] [Related]
7. Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody. Georges E; Tsuruo T; Ling V J Biol Chem; 1993 Jan; 268(3):1792-8. PubMed ID: 7678410 [TBL] [Abstract][Full Text] [Related]
8. Modulation of human P-glycoprotein epitope expression by temperature and/or resistance-modulating agents. Jachez B; Cianfriglia M; Loor F Anticancer Drugs; 1994 Dec; 5(6):655-65. PubMed ID: 7534147 [TBL] [Abstract][Full Text] [Related]
9. Antibody C219 recognizes an alpha-helical epitope on P-glycoprotein. van Den Elsen JM; Kuntz DA; Hoedemaeker FJ; Rose DR Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13679-84. PubMed ID: 10570132 [TBL] [Abstract][Full Text] [Related]
10. Membrane topology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-terminal domain of mdr3. Kast C; Canfield V; Levenson R; Gros P Biochemistry; 1995 Apr; 34(13):4402-11. PubMed ID: 7535563 [TBL] [Abstract][Full Text] [Related]
11. Use of a peptide mimotope to guide the humanization of MRK-16, an anti-P-glycoprotein monoclonal antibody. Tang Y; Beuerlein G; Pecht G; Chilton T; Huse WD; Watkins JD J Biol Chem; 1999 Sep; 274(39):27371-8. PubMed ID: 10488067 [TBL] [Abstract][Full Text] [Related]
12. Mode of binding of anti-P-glycoprotein antibody MRK-16 to its antigen. A crystallographic and molecular modeling study. Vasudevan S; Tsuruo T; Rose DR J Biol Chem; 1998 Sep; 273(39):25413-9. PubMed ID: 9738009 [TBL] [Abstract][Full Text] [Related]
13. Selection of phage-displayed peptides mimicking an extracellular epitope of human MDR1-P-glycoprotein. Poloni F; Palumbo S; Cianfriglia M; Felici F Physiol Chem Phys Med NMR; 1995; 27(4):271-80. PubMed ID: 8768783 [TBL] [Abstract][Full Text] [Related]
14. Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell lines. Chu TM; Kawinski E; Lin TH Hybridoma; 1993 Aug; 12(4):417-29. PubMed ID: 7503940 [TBL] [Abstract][Full Text] [Related]
15. A new structural model for P-glycoprotein. Jones PM; George AM J Membr Biol; 1998 Nov; 166(2):133-47. PubMed ID: 9841738 [TBL] [Abstract][Full Text] [Related]
16. Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence. Kast C; Canfield V; Levenson R; Gros P J Biol Chem; 1996 Apr; 271(16):9240-8. PubMed ID: 8621583 [TBL] [Abstract][Full Text] [Related]
17. Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1). Liu B; Sun D; Xia W; Hung MC; Yu D J Natl Cancer Inst; 1997 Oct; 89(20):1524-9. PubMed ID: 9337349 [TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance P-glycoprotein monoclonal antibody JSB-1 crossreacts with pyruvate carboxylase. Rao VV; Anthony DC; Piwnica-Worms D J Histochem Cytochem; 1995 Dec; 43(12):1187-92. PubMed ID: 8537634 [TBL] [Abstract][Full Text] [Related]
19. Generation of a monoclonal antibody to P-glycoprotein peptides using tuberculin-PPD as a carrier. Bashir I; Sikora K; Foster CS Virchows Arch; 1998 Mar; 432(3):279-87. PubMed ID: 9532008 [TBL] [Abstract][Full Text] [Related]
20. Analysis of a novel cDNA encoding a C219-reactive peptide isolated from methotrexate-selected multidrug-resistant human leukemic cells. Norris MD; Gilbert J; Madafiglio J; Haber M Gene; 1995 Apr; 156(2):313-4. PubMed ID: 7758977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]